Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Export
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
Аll
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
Аll
2024
2023
2022
2021
2020
2019
2018
2017
04.09.2023
“Sacrificing myself for the sake of serving others”
Read more
29.08.2023
The Pharmasyntez Group of Companies at the XI Baikal Forum against HIV infection
Read more
23.08.2023
Nomides® suspension in new volumes
Read more
16.08.2023
The Adviser to the President and Minister of three Ministries (Science, Technology, and Education) of the Republic of Mozambique paid a working visit to Pharmasyntez-Nord JSC on the government delegation.
Read more
04.08.2023
The government delegation from the Republic of Zimbabwe visited Pharmasyntez-Nord
Read more
01.08.2023
The Pharmasyntez Group of Companies at the second Russia-Africa Summit
Read more
25.07.2023
The Pharmasyntez Group of Companies enters the Ecuador Market
Read more
24.07.2023
The Pharmasyntez Group of Companies is in the TOP 3 pharmaceutical companies in terms of supplies in the 1st quarter of 2023
Read more
14.07.2023
Increase in cancer incidence: challenges and statistics
Read more
13.07.2023
The Pharmasyntez Group of Companies enters the Syrian Market
Read more
05.07.2023
Summer internship at the Pharmasyntez-Tyumen plant
Read more
03.07.2023
The Pharmasyntez Group of Companies starts production of gensulins in Russia
Read more
27.06.2023
"A powerful energy boost and a sense of unity"
Read more
18.06.2023
It was hot!
Read more
15.06.2023
The Pharmasyntez Group is investing 5 billion rubles in the construction of the fourth stage of the Pharmasyntez-Nord pharmaceutical complex
Read more
15.06.2023
Pharmasyntez and Irkutsk Region defined social activities for 2023
Read more
News:
← предыдущая
1
2
3
4
5
следующая →
About
History
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
Cardiology
Corticoid hormones
COVID-19
Drugs for the treatment of diabetes mellitus
Endocrinology
Gynecology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
MRI agents
Multiple sclerosis
Neuroleptics
Neurology
Nonsteroidal anti-inflammatory drug
Nootropics
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
X-ray contrast agents
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Export
Possibilities
News
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez